These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32066227)

  • 1. Are alternative antibiotics needed for antibiotic-nonresponsive Mycoplasma pneumoniae pneumonia?
    Yang EA; Lee KY
    Clin Exp Pediatr; 2020 Feb; 63(2):44-45. PubMed ID: 32066227
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Lee H; Yun KW; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children.
    Yuan C; Min FM; Ling YJ; Li G; Ye HZ; Pan JH; Wang L; Xie YP
    Comb Chem High Throughput Screen; 2018; 21(10):749-754. PubMed ID: 30636596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical analysis of antibiotic therapy of acute respiratory infections caused by Mycoplasma pneumoniae].
    Kuzman I; Petricević I
    Plucne Bolesti; 1989; 41(1-2):13-7. PubMed ID: 2508137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplasma pneumoniae and community-acquired pneumonia.
    Dey AB; Chaudhry R; Kumar P; Nisar N; Nagarkar KM
    Natl Med J India; 2000; 13(2):66-70. PubMed ID: 10835852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Gillies MB; Chang AB
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit.
    Miyashita N; Obase Y; Ouchi K; Kawasaki K; Kawai Y; Kobashi Y; Oka M
    J Med Microbiol; 2007 Dec; 56(Pt 12):1625-1629. PubMed ID: 18033831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma pneumoniae detection causes excess antibiotic use in Norwegian general practice: a retrospective case-control study.
    Foshaug M; Vandbakk-Rüther M; Skaare D; Grude N; Lindbæk M
    Br J Gen Pract; 2015 Feb; 65(631):e82-8. PubMed ID: 25624311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Bacterial Co-infection Invalidates the Early Use of Non-anti-
    Liu JR; Lu J; Dong F; Li HM; Liu H; Tang XL; Guo YL; Zhao SY
    Front Pediatr; 2018; 6():296. PubMed ID: 30416990
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent.
    Atmar RL; Greenberg SB
    Semin Respir Infect; 1989 Mar; 4(1):19-31. PubMed ID: 2496449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IN VITRO ANTIBIOTIC SENSITIVITY STUDIES OF MYCOPLASMA PNEUMONIAE.
    GRIFFITH RS; BLACK HR
    Curr Ther Res Clin Exp; 1964 Apr; 6():249-52. PubMed ID: 14173500
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
    Cao B; Qu JX; Yin YD; Eldere JV
    Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children.
    Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004875. PubMed ID: 16034954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycoplasma pneumoniae pneumopathy. 10 cases].
    Lesobre V; Azarian R; Gagnadoux F; Harzic M; Pangon B; Petitpretz P
    Presse Med; 1999 Jan; 28(2):59-66. PubMed ID: 9989294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of serum
    Dong Y; Lv W; Lin Z
    Exp Ther Med; 2017 Aug; 14(2):1445-1449. PubMed ID: 28810609
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents.
    Lee WJ; Huang EY; Tsai CM; Kuo KC; Huang YC; Hsieh KS; Niu CK; Yu HR
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma pneumonia in young children, 2-5 years of age.
    Bunnag T; Lochindarat S; Srisan P; Jetanachai P
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S124-7. PubMed ID: 19253507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.